MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy

A Inoue, SP Sheedy, JP Heiken… - Insights into …, 2021 - Springer
MRI is routinely used for rectal cancer staging to evaluate tumor extent and to inform
decision-making regarding surgical planning and the need for neoadjuvant and adjuvant …

Neoadjuvant chemotherapy without radiation in colorectal cancer

J Bhudia, R Glynne-Jones, T Smith… - Clinics in colon and …, 2020 - thieme-connect.com
In colon cancer, primary surgery followed by postoperative chemotherapy represents the
standard of care. In rectal cancer, the standard of care is preoperative radiotherapy or …

The conditioning of adjuvant chemotherapy for stage II and III rectal cancer determined by postoperative pathological characteristics in Romania

HD Liscu, BR Liscu, R Mitre, IV Anghel… - Medicina, 2023 - mdpi.com
The management of locally advanced rectal cancer (LARC) suffered changes thanks to the
development of improved surgical procedures, radiation delivery, and chemotherapy …

The incidence and prognosis value of perineural invasion in rectal carcinoma: from meta-analyses and real-world clinical pathological features

T Chen, B Zheng, P Yang, Z Zhang, Y Su, Y Chen… - Clinical Oncology, 2023 - Elsevier
Aims Perineural invasion (PNI) is a special type of metastasis of several cancers and has
been reported as being a factor for poor prognosis in colorectal carcinoma. However …

A clinical‐radiomics model incorporating T2‐weighted and diffusion‐weighted magnetic resonance images predicts the existence of lymphovascular invasion …

K Zhang, Y Ren, S Xu, W Lu, S Xie, J Qu… - Medical …, 2021 - Wiley Online Library
Purpose Lymphovascular invasion (LVI) and perineural invasion (PNI) are independent
prognostic factors in patients with colorectal cancer (CRC). In this study, we aimed to …

[HTML][HTML] Perineural invasion as a prognostic factor in patients with stage I-III rectal cancer–5-year follow up

MS Lalosevic, T Milovanovic, M Micev… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Rectal cancer (RC) is one of the most common diagnosed cancers, and one
of the major causes of cancer-related death nowadays. Majority of the current guidelines rely …

Establishment and clinical application of an artificial intelligence diagnostic platform for identifying rectal cancer tumor budding

S Liu, Y Zhang, Y Ju, Y Li, X Kang, X Yang, T Niu… - Frontiers in …, 2021 - frontiersin.org
Tumor budding is considered a sign of cancer cell activity and the first step of tumor
metastasis. This study aimed to establish an automatic diagnostic platform for rectal cancer …

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A …

YH Kuo, YT Lin, CH Ho, CL Chou, LC Cheng… - Frontiers in …, 2022 - frontiersin.org
Background For rectal cancer, it remains unclear how to incorporate tumor response to
neoadjuvant chemoradiotherapy (nCRT) when deciding whether to give adjuvant …

Comparative evaluation of CT and MRI in the preoperative staging of colon cancer

E Bompou, A Vassiou, I Baloyiannis, K Perivoliotis… - Scientific Reports, 2024 - nature.com
The aim of this study is to compare the diagnostic performance of magnetic resonance
imaging (MRI) against computed tomography (CT) in various aspects of local staging in …

Prognostic impact of tumor budding in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis

J Li, Y Ma, L Wen, G Zhang, C Huang, J Wang… - Systematic Reviews, 2024 - Springer
Background Tumor budding (TB) is a negative prognostic factor in colorectal cancer;
however, its prognostic impact following neoadjuvant therapy for patients with rectal cancer …